In contrast to other biomarkers, such as IL-6, CRP, D-dimers, and ferritin, suPAR increases earlier in COVID-19 patients, reflecting a higher risk of disease progression to respiratory failure and respiratory failure mortality [91, 96, 97]. The gene discussed is IL6; the disease is respiratory failure.